Talphera (TLPH) Other Non-Current Liabilities (2010 - 2026)
Talphera (TLPH) posted quarterly Other Non-Current Liabilities of $1.2 million for Q1 2026, up 31.02% year-over-year from $880000.0 in Q1 2025, and down 51.47% quarter-over-quarter from $2.4 million in Q4 2025.
Talphera (TLPH) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Talphera's Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 31.02% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (up 31.02% YoY), while the FY2025 annual figure was $2.4 million, up 123.94% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $1.2 million, down from $2.4 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $84.6 million in Q1 2022, with the low at $759000.0 in Q2 2025.
- The 5-year median for Other Non-Current Liabilities is $1.9 million (2025), against an average of $8.5 million.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities jumped 46648.62% in 2022, then sank 97.89% in 2023.
- Talphera's Other Non-Current Liabilities stood at $7.1 million in 2022, then plunged by 74.95% to $1.8 million in 2023, then slumped by 40.33% to $1.1 million in 2024, then jumped by 123.94% to $2.4 million in 2025, then sank by 51.47% to $1.2 million in 2026.
- Business Quant data shows TLPH's Other Non-Current Liabilities at $1.2 million in Q1 2026, $2.4 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Talphera | 90.25 Mn | 90.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 Mn |
| Mar 31, 2026 | 1.15 Mn |
| Dec 31, 2025 | 2.38 Mn |
| Sep 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 759,000.00 |
| Mar 31, 2025 | 880,000.00 |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.33 Mn |
| Mar 31, 2024 | 2.78 Mn |
| Dec 31, 2023 | 1.78 Mn |
| Mar 31, 2023 | 1.79 Mn |
| Dec 31, 2022 | 7.10 Mn |
| Mar 31, 2022 | 84.62 Mn |
| Dec 31, 2021 | 85.29 Mn |
| Sep 30, 2021 | 109,000.00 |
| Jun 30, 2021 | 128,000.00 |
| Mar 31, 2021 | 181,000.00 |
| Dec 31, 2020 | 88.37 Mn |
| Sep 30, 2020 | 506,000.00 |